Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB vs FICB for Pain After Total Hip Prosthesis
NCT05621161Completed
- Start
- Nov 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine hydrochloride 0.75% injection in hip osteoarthritis (2 arms). Primary endpoint: Opioid consumption at 24 hours. Started Nov 2022; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on NCT05621161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05621161.